An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe Disease. [PDF]
Roberts ME +8 more
europepmc +1 more source
Elevated Cerebrospinal Fluid Total Tau in Niemann-Pick Disease Type C1: Correlation With Clinical Severity and Response to Therapeutic Interventions. [PDF]
Cawley NX +15 more
europepmc +1 more source
Early Diagnosis of Nieman-Pick Disease Type C and Rapid Response of Gelastic Cataplexy to Treatment With N-Acetyl-L-Leucine: A Case Report. [PDF]
Rojnueangnit K +3 more
europepmc +1 more source
Biomarker Validation in NPC1: Foundations for Clinical Trials and Regulatory Alignment. [PDF]
Casazza K +4 more
europepmc +1 more source
Niemann-Pick C-like Endolysosomal Dysfunction in DHDDS Patient Cells, a Congenital Disorder of Glycosylation, Can Be Treated with Miglustat. [PDF]
Best HL +3 more
europepmc +1 more source
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data. [PDF]
van der Beek NAME +2 more
europepmc +1 more source
Targeting Glucosylceramide Synthase: Innovative Drug Repurposing Strategies for Lysosomal Diseases. [PDF]
Canini G +4 more
europepmc +1 more source
<i>N</i>-Alkyl Derivatives of Deoxynojirimycin (DNJ) as Antiviral Agents: Overview and Update. [PDF]
Checconi P +10 more
europepmc +1 more source

